RBC Doubles Down on Dyne Therapeutics with Significant Stake Increase

Royal Bank of Canada has significantly increased its stake in Dyne Therapeutics, Inc. (NASDAQ:DYN) by purchasing an additional 49,641 shares during the first quarter.

The firm now owns 68,188 shares of Dyne Therapeutics stock after buying more shares, with a total value of $1,236,000 at the end of the most recent quarter.

This is not an isolated incident, as other institutional investors and hedge funds have also recently made changes to their positions in Dyne Therapeutics.